T10	Subject 83 111	patients with advanced NSCLC
T15	Treatment 32 44	tirapazamine
T16	Effect 45 79	enhances the activity of cisplatin
T12	Drug 32 44	tirapazamine
T14	Treat-Disorder 97 111	advanced NSCLC
T13	Potential_therapeutic_event 45 53	enhances
E1	Potential_therapeutic_event:T13